Dr. Lau is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
222 East 41st Street
9th Floor
New York, NY 10017Phone+1 212-263-7744Fax+1 212-263-7721- Is this information wrong?
Education & Training
- NYU Grossman School of MedicineFellowship, Child Neurology, 2007
- NYU Grossman School of MedicineFellowship, Neurogenetics, 2010 - 2011
- NYU Grossman School of MedicineResidency, Child Neurology, 2007 - 2010
- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 2005 - 2007
- University of Rochester School of Medicine and DentistryClass of 2005
- New York Medical CollegeM.Sc., Biochemistry & Molecular Biology, 1998 - 2001
- New York Medical CollegeMS, Biochemistry and Molecular Biology, -, 2001
- Cornell UniversityBS, Biology, Honors, 1994 - 1998
- Cornell UniversityB.S., General Biology, With honors, 1994 - 1998
Certifications & Licensure
- null, NY 2008 - 2025
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Joseph Collins Fellowship for Medical Students University of Rochester School of Medicine & Dentistry, 2001
- Research Honor’s Thesis Cornell University, 1998
Clinical Trials
- Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP) Start of enrollment: 2005 Jul 01
- A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE) Start of enrollment: 2009 Nov 01
- A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE) Start of enrollment: 2009 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Reply to Mistry et al. The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on "Hughes et al. Switching between Enzyme Replacem...Derralynn A Hughes, Patrick Deegan, Pilar Giraldo, Özlem Göker-Alpan, Heather Lau, Elena Lukina, Shoshana Revel-Vilk, Maurizio Scarpa, Jaco Botha, Noga Gadir, Ari Zimran> ;Journal of Clinical Medicine. 2023 Jun 13
- Letter response: Intra-familial phenotype variability in Late-Onset Tay-Sachs disease.Giulietta Maria Riboldi, Heather Lau> ;Tremor and Other Hyperkinetic Movements. 2023 Jan 1
- 14 citationsFirst-in-human in vivo genome editing via AAV-zinc-finger nucleases for mucopolysaccharidosis I/II and hemophilia B.Paul Harmatz, Carlos E Prada, Barbara K Burton, Heather Lau, Craig M Kessler, Liching Cao, Marina Falaleeva, Andres G Villegas, Jennifer Zeitler, Kathleen Meyer, Westo...> ;Molecular Therapy. 2022 Dec 7
- Join now to see all
Journal Articles
- Multi-domain impact of elosufase alfa in Morquio A syndrome: assessments of tertiary endpoints from the pivotal phase III trialHendriksz CJ, Giugliani R, Harmatz P, Mengel E, Guffon N, Valayannopoulos V, Parini R Hughes D, Pastores GM, Lau HA, Al-Sayed MD; Raiman J, Jin D, STRIVE Investigat..., Mol Genet Metab, 9/6/2014
- Shear-wave ultrasonography evaluation of human skeletal muscle in healthy subjects versus those with GNE-related myopathyCarpenter E, Lau H, Kolodny E, Adler R, Radiology, 9/1/2014
- Branching Enzyme Deficiency: Expanding the Clinical SpectrumParadas C, Akman HO, Ionete C, Lau H, Riskind PN, Jones DE, Smith TW, Hirano M, Dimauro S, JAMA Neurol, 11/18/2013
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- A Controlled PHASE 2 Study of Sialic Acid-extended Release (SA-ER) IN GNE MyopathyZ. Argov, Y. Caraco, H. Lau, A. Pestronk, P. Shieh, A.M. Skrinar, J. Mayhew, J. Martinisi, E Kakkis, ICNMD, 7/1/2014
- Oral Sialic Acid Extended Release (SA-ER) Stabilizes Upper Extremity Muscle Strength in Human GNE Myopathy: A Phase 2 StudyZ. Argov, MD, Y. Caraco, MD, H. Lau, MD, A. Pestronk, MD, P. Shieh, MD, A. M. Skrinar,J. Mayhew, J. Martinisi and E. Kakkis, MD Ph.D., AAN, 5/1/2014
- Longitudinal studies of brain structure and function in MPS disorders: a study of the lysosomal disease networkShapiro, Elsa; Delaney, Kathleen; King, Kelly; Nestrasil, Igor; Ahmed, Alia; Raiman, Julian; Harmatz, Paul; Lau, Heather; Shankar, Suma; Cowan, Morton; Whitley, Chester B, Molecular genetics & metabolism, 1/1/2014
- Join now to see all
Lectures
- Randomized controlled phase 2 study of GNE myopathy subjects treated with placebo, 6g or 3g doses of extended-release sialic acid (SA-ER) and an extension study at a ...Berlin - 10/11/2014
- GNE-related myopathy: Clinical presentation Of 16 Patients and Discussion of Emerging Therapies1/1/2014
- Spectrum of disease in Canavan1/1/2014
- Join now to see all
Press Mentions
- How Stephen Hawking Was Able to Live for so Long with ALSMarch 14th, 2018
- Ultragenyx’s Gene Therapy Ameliorates Pediatric Neurodegenerative DisorderFebruary 8th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: